New therapies for stroke

Archives of Neurology

Volumn 54, Issue 10, 1997, Pages 1222-1224

  Caplan, Louis R ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PERFUSION; DIAGNOSTIC IMAGING; DISEASE SEVERITY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOEMBOLISM;

EID: 0030767117     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550220032010     Document Type: Review

References (11)

1. Higashida RT, Halbach W, Tsai FY, Dowd CF, Hieshima GB. Interventional neurovascular techniques for cerebral revascularization in the treatment of stroke. AJR Am J Roentgenol. 1994;163:793-800.
2. Pessin MS, del Zoppo GJ, Furlan AJ. Thrombolytic treatment in acute stroke: review and update of selective topics. In: Moskowitz M, Caplan LR, eds. Cerebrovascular Diseases. Nineteenth Princeton Stroke Conference. Boston, Mass: Butterworth-Heinemann; 1995:409-418.
3. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
5. Tsai FY, Berberian B, Matovich V, Lavin M, Alfieri K. Percutaneous transluminal angioplasty adjunct to thrombolysis for acute middle cerebral artery rethrombosis. AJNR Am J Neuroradiol. 1994;15:1823-1829.
6. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
7. Antiplatelet-Trialists Collaboration. Collaborative overview of randomized trials of antiplatelet treatment, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelettherapy in various categories of patients. BMJ. 1994;308:81-106.
8. Mohr JP and the WARSS Group. Design considerations for the Warfarin-Antiplatelet Recurrent Stroke Study. Cerebrovasc Dis. 1995;5:156-157.
9. Fisher M. Prophylactic Neuroprotection in Stroke Therapy. Boston, Mass: Butterworth-Heinemann; 1995:233-245.
10. Onal MZ, Fisher M. Thrombolytic and cytoprotective therapies for acute ischemic stroke: a clinical overview. Drugs Today. 1996;32:573-592.
11. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke: further evidence. Stroke. 1995;26:2254-2259.